PM
Priyank Misra
About Priyank Misra
Data last updated:
Priyank Misra is a Director at Elixir Vitae Pharmaceuticals Private Limited (since 2021) and Director at Requital Pharmaceuticals Private Limited (since 2020). The companies operate in Trading. The largest current company by reported revenue is Elixir Vitae Pharmaceuticals Private Limited at ₹17.8 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Elixir Vitae Pharmaceuticals Private Limited U51909UP2021PTC149223 | Director | 22 Jul 2021 | 2021 | ₹17.8 Lakh (FY 2024) | Active |
| Requital Pharmaceuticals Private Limited U51909GJ2020PTC118312 | Director | 19 Nov 2020 | 2020 | Active |
Board colleagues of Priyank Misra
| Name | DIN | Company | Designation |
|---|---|---|---|
| Manish Mishra | 08965360 | Elixir Vitae Pharmaceuticals Private Limited , Requital Pharmaceuticals Private Limited | Director |
| Anjali Srivastava | 08965358 | Requital Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Priyank Misra
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Priyank Misra
Priyank Misra currently holds 2 directorships: Elixir Vitae Pharmaceuticals Private Limited (Director, since 22 Jul 2021, revenue ₹17.8 Lakh (FY 2024)); Requital Pharmaceuticals Private Limited (Director, since 19 Nov 2020).
Priyank Misra was first appointed on 19 Nov 2020 as Director at Requital Pharmaceuticals Private Limited. The most recent appointment on record is 22 Jul 2021 at Elixir Vitae Pharmaceuticals Private Limited.
The current boards of Priyank Misra's companies include Manish Mishra (Elixir Vitae Pharmaceuticals Private Limited), Anjali Srivastava (Requital Pharmaceuticals Private Limited).